Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Dougados, Maxime; van der Heijde, Désirée; Sieper, Joachim; Braun, Jürgen; P Maksymowych, Walter; Citera, Gustavo; Miceli-Richard, Corinne; Cheng-Chung Wei, James; Pedersen, Ron; Bonin, Randi; U Rahman, Mahboob; Logeart, Isabelle; Wajdula, Joseph; S Koenig, Andrew; Vlahos, Bonnie; Alvarez, Daniel; F Bukowski, Jack

doi:10.1002/art.38721

Public

Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Shared by NobleBlocks on Aug 1, 2014 • 12:00 AM UTC

Authors:

Maxime Dougados

Désirée van der Heijde

Joachim Sieper

Abstract

OBJECTIVE: To assess the efficacy of etanercept in the treatment of early active nonsteroidal antiinflammatory drug (NSAID)-refractory nonradiographic axial spondyloarthritis (SpA). METHODS: The study population consisted of patients who met the Assessment of SpondyloArthritis international Society ...

Discussions